News | October 22, 2007

Osteoporosis Imaging to Predict Heart Attacks, Stroke

October 23, 2007 - Hologic Inc. today announced that a study has been published online in the Journal of Bone and Mineral Research that used single-energy vertebral fracture assessment (VFA) exams to measure abdominal aortic calcification, concluding that “…a high level of abdominal aortic calcification (AAC) detected on VFA images is predictive of incident myocardial infarction or stroke among elderly Caucasian women, independent of other clinical CVD (cardiovascular disease) risk factors.”

The study, titled "Abdominal Aortic Calcification Detected on Lateral Spine Images from a Bone Densitometer Predicts Incident Myocardial Infarction or Stroke in Older Women," indicates that physicians should use the opportunity of a VFA scan to look for evidence of cardiovascular disease.

“Previous work has shown that it is cost effective to do VFA scans in many postmenopausal women to detect vertebral fracture, and prescribe osteoporosis treatment medication when such a vertebral fracture is seen.” says lead author, John Schousboe, M.D. of Park Nicollet Health Services in Minneapolis, MN. “This is particularly important in women, since two-thirds of women who died suddenly of coronary heart disease have no prior symptoms.”

“This study found that AAC had a similar predictive strength for cardiovascular disease (CVD) as the Framingham Point score. The Framingham Point score combines the traditional risk factors of total cholesterol, HDL, blood pressure, hypertension treatment and smoking to predict 10-year cardiovascular heart disease risk” says co-author Eugene McCloskey, M.D., of Sheffield University, UK. “Additionally, we found that this predictive ability of AAC was independent of the all of the traditional CVD risk factors we collected in the study.”

For more information: www.hologic.com

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
CDN to Integrate Advanced Cardiac Imaging Tools From DiA Imaging Analysis
Technology | August 10, 2017
August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-g
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
3D printing of the heart and coronary artery tree from a patient's CT scan.
Sponsored Content | Webinar | 3-D Printing| August 09, 2017
Learn how 3-D printing empowers medical device manufacturer Medtronic to bring products to market faster, develop bet
Overlay Init